Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ebola Hemorrhagic Fever Vaccines
New ebola hemorrhagic fever vaccines study findings reported from Tulane University, University Health Science Center
May 21st, 2008
Research findings, 'Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions,' are discussed in a new report. According to recent research from the United States, "The filoviruses, Marburg and Ebola, have the dubious distinction of being associated with some of the highest case-fatality rates of any known infectious disease--approaching 90% in many outbreaks. In recent years, laboratory research on the filoviruses has produced treatments and vaccines that are effective in laboratory animals and that could potentially drastically reduce case-fatality rates and curtail outbreaks in humans." "However, there...
Source: Vaccine Weekly (2008-05-21)
|
